15908-53-9

159088-90-1 1(2H)-Quinolinepropanesulfonic acid,2-[4-(1,3-dibutyltetrahydro-4,6-dioxo-2-selenoxo-5(2H)-pyrimidinylidene)-2-butenylidene]-, compd. with N,N-diethylethanamine (1:1)

159086-01-8 butyl N-[(4E)-5-furan-2-yl-3-oxopent-4-en-1-yl]-L-isoleucinate

159092-73-6 3,10-DINITROPHENANTHRENE

159088-48-9 RAS INHIBITORY PEPTIDE

159086-05-2 methyl N-[(4E)-5-furan-2-yl-3-oxopent-4-en-1-yl]-L-methioninate

159092-75-8 4,10-Dinitrophenanthrene

159086-00-7 methyl N-[(4E)-5-furan-2-yl-3-oxopent-4-en-1-yl]-L-leucinate

15909-76-9 propanoic acid, 2,3-dihydroxy-, methyl ester

159092-74-7 4,9-Dinitrophenanthrene

159100-33-1 Siloxanes and Silicones, di-Me,3-hydroxypropyl Me, ethers with polyethylene glycol mono-10-undecenoate

159086-08-5 phenyl N-[(4E)-5-furan-2-yl-3-oxopent-4-en-1-yl]-L-tryptophanate

15908-53-9 Ethanone, 1-[5-methyl-3-(methylthio)-1-phenylpyrazol-4-yl]-

15909-94-1 5-(5-mercapto-1H-tetrazol-1-yl)isophthalic acid

159092-85-0 3,5,10-Trinitrophenanthrene

159082-78-7 Cyclopropaneacetic acid,1-[[[1-[3-[2-(2,3-dichlorothieno[3,2-b]pyridin-5-yl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, monosodium salt, (R)-

159088-44-5 2-(4,5-DICHLORO-1H-IMIDAZOL-1-YL)ACETONITRILE

159092-79-2 1,7,9-Trinitrophenanthrene

159092-81-6 2,6,9-Trinitrophenanthrene

15908-60-8 2-Propenamide, 3-amino-2-cyano-3-(methylthio)-

159092-09-8 2-Oxazolamine, N-[(3,4-dichlorophenyl)methyl]-4,5-dihydro-